21559 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a NS, NS, NS, N chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
Sub-classes:MOFS WITH BETA-EMITTERS FOR RADIOTHERAPY
#2PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#3ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
#4RADIOLABELLING KIT AND METHOD FOR RADIOLABELLING
#5METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES
#6ZWITTERIONIC METAL CHELATORS
#7ZWITTERIONIC METAL CHELATORS
#8FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS
#9ORGANOMETALLIC GOLD(III) COMPLEXES FOR RADIOLABELING BIOMOLECULES FOR APPLICATIONS IN POSITRON EMISSION TOMOGRAPHY (PET) MOLECULAR IMAGING
#10Alpha Emitter Compositions And Methods
#11LABELING PRECURSORS WITH SQUARIC ACID COUPLING
#12IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
#13COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#14Metallophore-Radionuclide Complex as Nuclear Imaging Contrast Agents
#15IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
#16METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES
#17ANTIMONY CHELATES FOR TARGETED AUGER THERAPY AND IMAGING DIAGNOSTICS
#18ZWITTERIONIC METAL CHELATORS
#19RADIOLABELED BIOMOLECULES AND THEIR USE
#20NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#21DUAL-MODE PROBE FOR DETECTING HYDROGEN SULFIDE AND USE THEREOF
#22Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (FAP-α)
#23BISPIDINE DERIVATIVES AND THE USE THEREOF
#24CONJUGATES COMPRISING COVALENT BINDERS FOR TARGETING INTRACELLULAR KRAS G12C PROTEINS
#25CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#26Methods and kits for preparing radionuclide complexes
#27LRRC15 ANTIBODIES AND CONJUGATES THEREOF
#28PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#29Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)
#30FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING
#31Double-labeled probe for molecular imaging and use thereof
#32COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#33NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF
#34TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#35NANOPARTICLE IMMUNOCONJUGATES
#36Methods and kits for preparing radionuclide complexes
#37Labeling precursors with squaric acid coupling
#38Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers
#39RADIOPHARMACEUTICAL COMPOUND AND COMPOSITION FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS, PROCESS FOR THE PREPARATION THEREOF, RELATED KIT AND USES THEREOF
#40NOVEL RADIOLABELLED COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER
#41INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS
#42METHOD FOR PRODUCING RADIOPHARMACEUTICAL AND RADIOPHARMACEUTICAL
#43Chelated PSMA Inhibitors
#44Chelating platform for delivery of radionuclides
#45Separation of Radiometals
#46ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
#47ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
#48RADIODRUG FOR DIAGNOSTIC/THERAPEUTIC USE IN NUCLEAR MEDICINE AND RADIO-GUIDED MEDICINE
#49COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#50METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS
#51Alpha emitter compositions and methods
#52CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#53Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereof
#54Multinuclear complexes and their preparation
#55MARKING PRECURSOR WITH SQUARIC ACID COUPLING
#56IMAGING AGENTS FOR RADIOLABELING EXOGENOUS AND ENDOGENOUS ALBUMIN
#57Methods for Cell Labeling and Medical Imaging
#58DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES
#59COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#60Tc-EDDA/HYNIC-iPSMA as a radiopharmaceutical for detecting the overexpression of prostate-specific membrane antigen
#61Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
#62Method of use for therapeutic bone agents
#63Methods and kits for preparing radionuclide complexes
#64Radiopharmaceutical compositions
#65KIT TECHNOLOGY FOR THE PRODUCTION AND LONG-TERM STORAGE OF ZR-89-PET RADIOPHARMACEUTICALS
#66CHELATING MOLECULES
#67Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
#68Diagnosis, treatment and prevention of neurotensin receptor-related conditions
#69Double-labeled probe for molecular imaging and use thereof
#70RADIOACTIVE ANTITUMOR AGENT
#71NANOPARTICLE IMMUNOCONJUGATES
#72IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
#73MULTINUCLEAR COMPLEXES AND THEIR PREPARATION
#74Bioavailable dithiocarbamate-metal complex particles, method of preparation and use thereof
#75LU-CONTAINING COMPOSITIONS AND METHODS OF PRODUCING THE SAME
#76Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
#77RADIOLABELED BIOMOLECULES AND THEIR USE
#78Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
#79KIT FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE
#80RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE
#81Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds
#82Tc-EDDA/HYNIC-iPSMA as a radiopharmaceutical for detecting the overexpression of prostate specific membrane antigen
#83Chelated PSMA inhibitors
#84Compositions for therapeutics, targeted PET imaging and methods of their use
#85PET imaging of zinc transport
#86Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
#87Chelating platform for delivery of radionuclides
#88CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#89Method of imaging with a chelating agent
#90Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
#91Isotope preparation method
#92Radioactive probe for detecting hydrogen sulfide
#93Copper-cysteamine and methods of use
#94Polymetalloxane, method for producing same, composition thereof, cured film and method for producing same, and members and electronic components provided with same
#95COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TARGETED DRUG DELIVERY
#96Composition for preventing or treating ischemic diseases, containing liposomes in which VEGF-derived peptides are supported
#97Radioimaging using low dose isotope
#98EVALUATION OF PRESENCE OF AND VULNERABILITY TO ATRIAL FIBRILLATION AND OTHER INDICATIONS USING MATRIX METALLOPROTEINASE-BASED IMAGING
#99CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#100METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES
#101Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
#102Methods for cell labeling and medical imaging
#103Radiopharmaceutical solutions with advantageous properties
#104COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#105RADIOIMMUNE COMPLEX, THERANOSTIC AGENT AND KIT
#106Alpha-emitting complexes
#107Molecular probes for multimodality imaging and tracking of stem cells
#108Development of neurokinin-1 receptor-binding agent delivery conjugates
#109Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
#110Compositions and methods for non-invasive imaging
#111Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
#112Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
#113Stabilized form of tetrofosmin and its use
#114Metal complexes and methods of treatment
#115Nitrogen-containing compound or salt thereof, or metal complex thereof
#116Pet imaging of zinc transport
#117Copper-cysteamine and methods of use
#118Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX
#119KIT FOR TUMOR IMAGING
#120Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
#121COMPOSITIONS AND METHODS OF DIAGNOSING OCULAR DISEASES
#122BIMODAL FLUOROPHORE-LABELED LIPOSOMES AND ASSOCIATED METHODS AND SYSTEMS
#123IMAGING FIBROSIS
#124Radioisotope trithiol complexes
#125Myocardial perfusion imaging methods and compositions
#126Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex
#127Molecular probes for multimodality imaging and tracking of stem cells
#128Radio-pharmaceutical complexes
#129Compositions and methods for non-invasive imaging
#130Radiolabeled prostate specific membrane antigen inhibitors
#131Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same
#132PET/SPECT agents for applications in biomedical imaging
#133Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof
#134Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
#135Gall bladder imaging agent and its preparation method
#136Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#137Radioimaging using low dose isotope
#138Compounds for diagnosing diseases associated with the expression of MUC5AC
#139Conjugates and their uses in molecular imaging
#140Myocardial perfusion imaging methods and compositions
#141Alpha-emitting complexes
#142BISAMINOETHANETHIOL-TARGETING LIGAND CONJUGATES AND COMPOSITIONS
#143IMAGING TUBERCULOSIS WITH PYRAZINAMIDE CONTRAST AGENTS
#144Radiopharmaceutical compositions
#145Miniaturized Zn/Cu generator for high concentration clinical delivery of Cu kit formulation for the facile preparation of radiolabeled Cu-bis(thiosemicarbazone) compounds
#146Radiolabeled prostate specific membrane antigen inhibitors
#147Compositions and methods for imaging tissues, organs and tumors
#148LABELLED INTEGRIN BINDERS
#149Myocardial perfusion imaging methods and compositions
#150Direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99M) and radiorhenium (Re-186, Re-188)
#151Bifunctional chelating agents
#152PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)
#153IMAGING AND RADIOTHERAPY METHODS
#154Aryl Bidentate Isonitriles and Their Uses
#155MEDICAL IMAGING PROCEDURES AND METHOD AND SYSTEM FOR MANAGING MEDICAL IMAGING PROCEDURES
#156Compounds for therapy and diagnosis
#157Compounds for imaging and therapy
#158Use of UTP for the diagnosis of stenoses and other conditions of restricted blood flow
#159Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid
#160Tame based chelators and uses thereof
#161PENDANT FATTY ACID IMAGING AGENTS
#162Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#163Radioactive mixture and manufacturing method thereof
#164CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
#165Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
#166Radioimaging applications of and novel formulations of teboroxime
#167Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same
#168COMPOUNDS AND METHODS FOR DETECTION OF CELLS
#169Diagnostic substance and method for the analysis of metabolism processes in the brain
#170Imaging protocols
#171Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use
#172Radionuclide Therapy for Urinary Bladder Cancer
#173Tumor imaging compounds
#174COMPOSITION FOR PREPARATION OF RADIOACTIVE PHARMACEUTICAL FOR DIAGNOSIS OF REGIONAL CEREBRAL BLOOD FLOW
#175Reconstruction stabilizer and active vision
#176INHIBITORS OF INTEGRIN VLA-4
#177Preparation of Triazole Containing Metal Chelating Agents
#178Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#179High dose radionuclide complexes for bone marrow treatment
#180PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS
#181Biotin-binding receptor molecules
#182IMAGING AGENTS FOR DIAGNOSIS OF PARKINSON'S DISEASE
#183Method of Diagnosing Prodromal Forms of Diseases Associated With Amyloid Deposition
#184Method of scintigraphy
#185Skeletal-targeted radiation to treat bone-associated pathologies
#186Metal complexes based on tetrathiol ligands and their use in nuclear medical diagnostics and endoradionuclide therapy and method for producing said metal complexes
#187Bridged aromatic substituted amine ligands with donor atoms
#188SMALL TECHNETIUM-99M AND RHENIUM LABELED AGENTS AND METHODS FOR IMAGING TUMORS
#189Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy
#190NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF
#191N4 chelator conjugates
#192Stilbene derivatives and their use for binding and imaging amyloid plaques
#193Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils
#194Technetium-99m-labeled organic germanium nanocolloids, method of preparing the same and use thereof
#195Perfluoroalkyl-containing complexes, process for their production as well as their use
#196Neutral labeling reactants and conjugates derived thereof
#197Crowned dithiocarbamate metal complexes and methods for their use
#198Tame based chelators and uses thereof
#199Pendant fatty acid imaging agents
#200Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging
#201Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
#202High dose radionuclide complexes for bone marrow suppression
#203Boat tropanes
#204Miniaturized 62zn/62cu generator for high concentration clinical delivery of 62cu kit formulation for the facile preparation of radiolabeled cu-bis(thiosemicarbazone)compounds
#205DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes
#206Poly(peptide) as a chelator: methods of manufacture and uses
#207Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
#208Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and NSconjugates for MR contrast media and radiopharmaceuticals
#209Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
#210Compound having affinity with calcified tissue
#211Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
#212Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
#213Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method
#214Skeletal-targeted radiation to treat bone-associated pathologies
#215Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
#216Opioid metallopeptide compositions and methods
#217Amyloid plaque aggregation inhibitors and diagnostic imaging agents
#218Radiopharmaceutical formulations
#219Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
#220Stilbene derivatives and their use for binding and imaging amyloid plaques
#221Bridged aromatic substituted amine ligands with donor atoms
#222Agents for imaging and diagnostic methods using them
#223Biphenyls and fluorenes as imaging agents in alzheimer's disease
#224Treatment of bone-associated cancers
#225Radiolabeled compounds and liposomes and their method of making and using same
#226Contrast agents
#227Tumor imaging compounds
#228Opioid metallopeptide compositions and methods
#229High dose radionuclide complexes for bone marrow suppression
#230Aminocarboxylate ligands having substituted aromatic amide moieties
#231Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
#232Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
#233Radiopharmaceutical formulations
#234High dose radionuclide complexes for bone marrow suppression
#235Phthalamide-lanthanide complexes for use as luminescent markers
#236Polypodal chelants for metallopharmaceuticals
#237Imaging agents for diagnosis of Parkinson's disease
#238Chelants and macrocyclic metal complex radiopharmaceuticals thereof